ilmscore | Prediction Details
By Finance With Sharan | December 17, 2025 | Correct
Interpreted Prediction
The drug Clopidogrel is identified as increasing the risk of coronary artery disease and bleeding in individuals with specific genetic predispositions.
AI Evaluation Notes
Clopidogrel's effectiveness is indeed influenced by genetic factors, particularly variations in the CYP2C19 gene. Individuals with certain CYP2C19 variants may have a reduced ability to convert clopidogrel to its active form, increasing the risk of adverse cardiovascular events.

Prediction Details

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.